In a continuing trend within the pharma industry, Elan has signed a deal for the CRO firm PPD to act as the primary service provider for all its development activities.
Many pharma companies have recently inked deals handing over varying degrees of development responsibility to CROs. Covance in particular has...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?